Young Non-Smoker Faces Stage Four ALK-Positive Lung Cancer After Persistent Cough
Jade Fardon, a 33-year-old from Watford who never smoked, was diagnosed with stage four ALK-positive lung cancer after a cough was repeatedly dismissed as COVID-19.
In 2020 Jade Fardon, a 33-year-old business change manager from Watford, England, consulted her GP about a persistent cough that was repeatedly blamed on COVID-19. After developing a hoarse voice, fatigue and night sweats, she compiled her symptoms and was referred for a CT scan in April 2022, which uncovered extensive ALK-positive lung cancer across both lungs at stage four. She avoided chemotherapy, instead taking a daily oral drug that shrank the tumors and allowed her to return to work.
In December 2023, scans identified 17 brain lesions, leading to gamma-knife radiation in January 2024; one lesion later progressed, causing a bleed that required brain surgery at the National Hospital for Neurology and Neurosurgery. Ongoing treatment now includes a new oral medication, regular MRI and CT monitoring, and she has shifted care to the private sector while continuing to work part-time. Fardon is raising funds for ALK Positive UK by completing Chris Hoy’s Tour De 4 charity cycle, aiming to challenge assumptions about living with incurable stage-four cancer.
Why it matters
The story highlights how lung cancer can affect young, non-smokers and the importance of early detection and targeted therapies.
In this story
